Language selection

Search

Patent 2196316 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 2196316
(54) English Title: SYRINGE WITH CANNULA-PROTECTING SHEATH AND SEALING CENTER ROD
(54) French Title: SERINGUE AVEC UNE GAINE PROTEGEANT LA CANULE ET UNE TIGE CENTRALE D'ETANCHEITE
Status: Expired
Bibliographic Data
(51) International Patent Classification (IPC):
  • A61M 5/32 (2006.01)
  • A61M 5/28 (2006.01)
  • A61M 5/31 (2006.01)
(72) Inventors :
  • BALABAN, STEPHEN MICHAEL (United States of America)
  • SMITH, JONATHAN PAUL (United States of America)
(73) Owners :
  • ELI LILLY AND COMPANY (United States of America)
(71) Applicants :
  • MONSANTO COMPANY (United States of America)
(74) Agent: GOWLING LAFLEUR HENDERSON LLP
(74) Associate agent:
(45) Issued: 2006-10-03
(86) PCT Filing Date: 1995-07-14
(87) Open to Public Inspection: 1996-02-15
Examination requested: 2002-07-03
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): Yes
(86) PCT Filing Number: PCT/US1995/008719
(87) International Publication Number: WO1996/004031
(85) National Entry: 1997-01-29

(30) Application Priority Data:
Application No. Country/Territory Date
08/283,324 United States of America 1994-08-01

Abstracts

English Abstract



A syringe assembly is comprised
of a plunger (12), a syringe
barrel (14) having a cannula
collar (34) at one end of
the barrel and an interior
chamber (36) within the barrel, a
hollow cannula (38) secured within
the syringe barrel collar (34) with
the cannula (38) extending axially
from the collar to its distal
end, a bore (52) extending axially
through the cannula (38) and the
syringe barrel collar (34), a
segment of the bore decreasing (e.g.,
tapering) in diameter as it extends
in a direction from the proximal end (42) of the cannula (38) toward the
barrel interior chamber (36), and a sheath (16) removably attached
to the syringe barrel (14) and covering the cannula (38), the sheath (16)
being affixed to a center rod (68) extending axially from the sheath
into the bore (52) at the cannula proximal end and then sealing engagement
with said segment of the interior bore (52).


French Abstract

Une seringue est constituée d'un piston (12), d'un cylindre (14) de seringue ayant un collier (34) pour canule à une extrémité et une chambre interne (36). Une canule creuse (38) est tenue à l'intérieur du collier (34) du cylindre de seringue et elle fait saillie axialement depuis le collier. Un canal (52) traverse axialement la canule (38) et le collier (34) du cylindre de la seringue. Une portion du canal diminue en diamètre (se rétrécit) en allant de l'extrémité proximale (42) de la canule (38) vers la chambre interne (36) du cylindre. Une gaine amovible (16) est placée sur le cylindre (14) de la seringue et elle couvre la canule (38). Cette gaine (16) est fixée à une tige centrale (68) s'étendant axialement depuis la gaine et s'engageant dans le canal (52) jusqu'à l'extrémité proximale de la canule où elle vient se loger d'une manière étanche dans le canal interne (52).

Claims

Note: Claims are shown in the official language in which they were submitted.



-10-

What is Claimed is:

1. In a syringe that is prefilled
with a substance for both storing the substance
within the syringe and later ejecting the substance
from the syringe, the improvement comprising:
a syringe barrel having an axial length with a
cannula collar at one end of the barrel length and an
interior chamber within the barrel;
a hollow cannula having axially opposite proximal
and distal ends, the proximal end being secured to
the syringe barrel collar with the cannula extending
axially from the collar to its distal end;
a bore having a length extending axially through
the cannula and the syringe barrel collar between the
cannula distal end and the syringe barrel interior
chamber, the bore having an interior surface where at
least a segment of the length of the bore changes in
diameter from a first interior diameter of the bore
to a second interior diameter of the bore, less than
the first interior diameter, as the bore extends in
the direction from the cannula distal end to the
barrel interior chamber through the bore segment;
and,
a center rod removably inserted axially into the
bore at the cannula distal end and seating in a
sealing engagement with said segment of the interior
bore.

2. The syringe of Claim 1, further comprising:
the bore interior surface along the segment of
the bore tapers from the first interior diameter to
the second interior diameter.

3. The syringe of Claim 1 or 2 further comprising:
a sheath removably attached to the syringe barrel
and covering the cannula, the sheath being affixed to
the center rod.

4. The syringe of Claim 2, wherein:


-11-

the tapered portion of the interior bore is adja-
cent the cannula proximal end and is spaced from the
cannula distal end.

5. The syringe of Claim 2, wherein:
the bore between the cannula distal end and the
tapered segment of the bore has an interior diameter
equal to the first interior diameter.

6. The syringe of Claim 2, wherein:
the tapered segment of the bore is within the
collar.

7. The syringe of any one of Claims 1 to 6, wherein:
the bore extends through the cannula between its
distal and proximal ends and then through the barrel
collar between the cannula proximal end and the
barrel interior chamber.

8. The syringe of Claim 2, wherein:
the rod length extends completely through the
tapered segment of the bore.

9. The syringe of Claim 2, wherein:
the rod is constructed of a resilient material
that is compressed within said segment of the bore
when the rod is inserted into the bore, thereby
seating a portion of the rod in sealing engagement
with said segment of the bore.

10. The syringe of Claim 9, wherein:
the portion of the rod that seats in sealing
engagement has a circular cross section with a cross
section diameter which, while the rod is not
compressed, is larger than the second interior
diameter of the interior bore.

11. The syringe of Claim 6, wherein:
the collar is constructed of a resilient material
that is compressed within at least a portion of the
tapered segment of the bore while the rod is inserted
into the bore thereby seating a portion of the rod in
sealing engagement with the portion of the tapered
segment of the bore.




-12-

12. The syringe of Claim 9, wherein:
the tapered segment of the bore is within the
collar and the collar is constructed of a resilient
material that is compressed within at least a portion
of the tapered segment of the bore when the rod is
inserted into the bore, thereby seating a portion of
the rod in sealing engagement with said portion of
the tapered segment of the bore.
13. The syringe of Claim 10, wherein:
the rod has a constant cross section diameter
along its length.
14. The syringe of Claim 2, wherein:
the rod has a length with a proximal end inserted
into the bore and a distal end outside the bore,
and a portion of the rod length near its proximal end
has a cross section diameter smaller than that of a
remainder of the rod length.
15. The syringe of Claim 3, wherein:
the rod has a length such that the rod length
extends completely through the tapered segment of the
bore.
16. The syringe of Claim 3, wherein:
the rod is constructed of a resilient material
that is compressed within at least a portion of the
tapered segment of the bore when the rod is inserted
into the bore, thereby seating a portion of the rod
in sealing engagement with said portion of the
tapered segment of the bore.
17. The syringe of Claim 16, wherein:
the portion of the rod that seats in sealing
engagement has a circular cross section having a
diameter which, while the rod is not compressed, is
larger than the second interior diameter of the inte-
rior bore.
18. The syringe of Claim 3, wherein:
the tapered segment of the bore is within the
collar and the collar is constructed of a resilient




-13-

material that is compressed within at least a portion
of the tapered segment of the bore while the sheath
is attached to the syringe barrel, thereby seating a
portion of the rod in sealing engagement with said
portion of the tapered segment of the bore.
19. The syringe of Claim 16, wherein:
the tapered segment of the bore is within the
collar and the collar is constructed of a resilient
material that is compressed within at least a portion
of the tapered segment of the bore while the sheath
is attached to the syringe barrel, thereby seating a
portion of the rod in sealing engagement with said
portion of the tapered segment of the bore.
20. The syringe of Claim 17, wherein:
the rod has an essentially constant cross section
diameter along its length.
21. The syringe of Claim 3, wherein:
the rod has a length with a proximal end inserted
into the bore and a distal end outside the bore and
affixed to the sheath, and a portion of the rod
length near its proximal end has a cross section
diameter smaller than that of a remainder of the rod
length.

Description

Note: Descriptions are shown in the official language in which they were submitted.



. . 2196316
iW0 96104031 PCTlUS95108719
-1-
SYRTNG~ WT'T'H CANNULA-PROTECTING SHEATH
AND SEALING CENTER ROD
O
The present invention pertains to a syringe of


the type that is prefilled/with a substance for both


storing the substance within the syringe and later


ejecting the substance from the syringe, e.g., to


inject the substance into the body of an animal. The


syringe is comprised of a plunger, a syringe barrel,


a cannula projecting from one end of the barrel or
a


cannula collar affixed thereto, and a removable


sheath attached to the syringe barrel and covering


the cannula to shield it from contamination and/or


unwanted contacts prior to desired ejection of the


substance from the syringe. A center bore extends


through the cannula to the interior chamber of the


syringe barrel. At least a segment of the bore


changes (e.g., tapers) to a smaller diameter in the


direction extending from the cannula distal end to


the interior chamber of the syringe barrel. The


sheath has a center rod affixed thereto that extends


axially from the sheath through the cannula and seats


in a sealing engagement with at least said segment
of


the interior bore, sealing the substance within the


syringe barrel interior chamber until such time as


ejection is desired.


The syringe of this invention has various


advantages in addition to the cannula-shielding


feature mentioned above. These advantages include


greater ease of use, compared to commonly used


techniques such as (1) affixing a cannula to a


prefilled syringe barrel before injecting the


substance through the cannula and (2) draw-up of the


injectable substance through a pre-attached cannula


into the syringe barrel from which it isexpelled


during a subsequent injection. Other important


.



R'O 96t04031 2 ~ 9 b 3 ~ ~ PC°fIiTS95l08719
-a-
advantages of the aforementioned sealing engagement
are that it (1} prevents leakage of the substance
r
from the syringe barrel intothe sheath during
storage of the syringe and (2} prevents any solid
particles which settle or precipitate out of the
substance stored in the syringe from accumulating in
the cannula and then clogging or restricting flow of
the substance through the cannula at the time of
desired injection.
l0
I?ESCRIFTION OF THE RELATED ART
There are various kinds of known prefilled
syringes, e.g., those having interior chambers that
store a substance prior to its ejection from the
syringe. Prefilled syringes are often,used where a
large number of injections are to be made in as short
a time period as possible and with as little
difficulty as possible. Syringes of this type have
found uses in injecting praphylactic, therapeutic and
stimulative substances.
One example of a beneficial use of prefilled
syringes is in injecting herds of livestock. For
example, in a dairy herd containing many animals, use
of prefilled syringes where each is used to inject a
measured dose of a substance into one animal of the
herd enables the injections of the herd to take place
with a considerable savings of time and effort.-
To reduce the cost of the disposable, prefilled
syringes, they typically have a simple construction
and are comprised of a syringe barrel with an
interior chamber, a plunger inserted into the chamber
at one end of the barrel, a cannula extending from
the opposite end of the barrel, and in some instances
a cannula cap or sheath. Over time, when particular
substances are stored in the conventional syringe
described above, for example a substance containing
solids or particulate matter suspended or dissolved


'V1'0 96/04031 219 6 316 1,C.1,~S95/08719
Y
-3-
in a liquid or gel, the solids may settle out or


precipitate in the form of particles that can collect



in the interior bore of the cannula and clog the


thus preventing or restricting delivery of the
bore


,


substance through the cannula when that is desired,


e.g., when the syringe plunger is pushed through the


syringe barrel=interior chamber to eject the


substance from-the syringe.


Certain prior art syringes have been constructed


with rods extending through the center of the syringe


cannula, some with a cap on the rod that seats over


the cannula tip to prevent the substance stored in


the syringe from leaking prematurely from the


cannula. However, these prior art rods have been


generally constructed with a diameter smaller than


the diameter of the cannula bore. No steps have been


taken to seal the cannula interior bore from the


barrel interior chamber, even with the rod inserted


through the bore. With such prior art devices, there


is an undesirable potential for solid particles to


settle or precipitate out of the substance stored in


the syringe interior chamber and leak into and become


lodged within the cannula, i.e.,. within the space


between the interior bore of the cannula and the


surface of the rod inserted in the interior bore.


Although removal of the rod from the cannula will


provide a flow path through the interior bore for the


substance contained in the syringe interior chamber,


solid particles that have settled or precipitated out


of the substance and have become lodged along the


' interior surface of the cannula bare will slow and/or


partially restrict the flow of the-.substance through


the cannula bore as the syringe plunger is pushed to


eject the substance from the syringe interior


chamber.


F..
Y ,.. ... .__..
_ __ .:: __e.

CA 02196316 2005-10-04
- 4 -
SUMMARY OF THE INVENTION
In accordance with one embodiment of the present
invention there is provided in a syringe that is prefilled
with a substance for both storing the substance within the
syringe and later ejecting the substance from the syringe,
the improvement comprising: a syringe barrel having an axial
length with a cannula collar at one end of the barrel length
and an interior chamber within the barrel; a hollow cannula
having axially opposite proximal and distal ends, the
proximal end being secured to the syringe barrel collar with
the cannula extending axially from the collar to its distal
end; a bore having a length extending axially through the
cannula and the syringe barrel collar between the cannula
distal end and the syringe barrel interior chamber, the bore
having an interior surface where at last a segment of the
length of the bore changes in diameter from a first interior
diameter of the bore to a second interior diameter of the
bore, less than the first interior diameter, as the bore
extends in the direction from the cannula distal end to the
barrel interior chamber through the bore segment; and, a
center rod removably inserted axially into the bore at the
cannula distal end and seating in a sealing engagement with
said segment of the interior bore.
The syringe of this invention is constructed with a
syringe barrel having a hollow interior chamber. Generally,
a cannula collar is provided at one end of the barrel and a
plunger extends into the interior chamber at the opposite
end of the barrel. The cannula is secured to the syringe
barrel collar, and in a preferred embodiment is seated on a
shoulder (e.g., circular) of the collar which prevents the
cannula from being pushed into the syringe barrel, e.g.,
when a force is exerted on the distal end of the cannula
when an injection is initiated. A hollow interior bore

CA 02196316 2005-10-04
- 4a -
extends axially through the center of the cannula and
through the syringe barrel collar as it extends from the
cannula tip to the syringe barrel interior chamber.
Generally, a first segment of the interior bore has a
substantially constant interior diameter as it extends
through the length of the cannula. Normally, a second
segment of the interior bore tapers to a smaller diameter,
e.g., as it extends through the syringe barrel collar,
although the decrease in diameter can be abrupt, if desired,
rather than gradual. In a preferred embodiment, the second
segment tapers from a first interior diameter that is
substantially equal to the interior diameter of the bore
within the cannula, to a second, smaller interior diameter
of the bore segment at the exit of the bore into the syringe
barrel interior chamber.
A sheath is attached removably (e.g., by force fit of a
sheath made of a resilient material) to the syringe barrel
and essentially completely covers the cannula. The sheath
has a center rod affixed to the sheath in the sheath
interior. The center rod is removably inserted into the
bore at the cannula distal end and preferably, but not
necessarily.

' 9 6 6
f '~ ~ 31


R 96/04031
O PCTIUS95/08719


-5-


extends through the complete
length of the bore while


thesheath is attached to the
syringe barrel.


In a preferred embodiment, the
center rod has a


substantially constant exterior
diameter along its



length. The rod diameter is smaller
than the


interior diameter of the first
segment of the bore,


and is larger than the interior
diameter of the


second segment of the bore. Thus,
as the center rod


is inserted into and through
the interior bore, the


rod wedges within the bore at
the location where the


interior diameter of the bore
becomes (e. g., tapers


to) less than that of the rod,
thus producing a


seal.


Preferably, both the syringe
barrel collar and


the sheath center rod are constructed
of resilient


plastic materials) that compresses)
slightly as the


rod is wedged~into the smaller-diameter
segment of


the bore, thereby providing a
sealed engagement of


the rod with that segment of
the bore. This sealed


engagement between the rod and
thesecond segment of


the bore is most desirably situated
at the opening of


the bore to the syringe barrel
interior chamber,


preventing-any of the substance
contained in the


chamber from entering the bore
until the rod is


removed from the cannula.


BRIEF DESCRIPTION OF THE DRAWINGS


Further objects and features
of the present


invention are revealed in the
following detailed


description of the preferred
embodiment of the


invention and in the drawing
figures wherein:


Figure 1 is a side elevation
view of the sheath


and syringeof the present invention;


Figure 2 is a partial view, in
section, showing


detail of the sheath and syringe
of the invention;


Figure 3 is a partial view, in
section, taken in


a plane along the line 3-3 of
Figure 2; and,





W096I04031 219 6 316 PCT/US95I08719
-6-
Figure 4 is a partial view, in section, similar
to that of Figure 3 showing the sheath center rod
,.
withdrawn from the tapered portion of the syringe
bore.
r
nccrnrymTON OF THE PREFERRED EMBODIMENTS
The syringe 10 of 'the present invention is shown
assembled in Figure d. Basically, the syringe 10 is
comprised of a syringe plunger 12, a syringe barrel
14 and a protective sheath 16. In the preferred
embodiment of the invention, these basic component
parts are all constructed of a resilient, plastic
material, for- example polyethylene or polypropylene.
Plunger 12 is slidably received within the barrel 14,
and sheath 16 is removably attached to the end of
barrel 14. Plunger 12-includes an elongated rod 22
with a finger push tab 24 at one end and a sealing
piston 26 at its opposite end (shown in Figure 2).
The syringe barrel 14 has a cylindrical, tubular
configuration with finger flanges 32 at one end and a
cannula collar 34 at the axially opposite end of the
elongated barrel 14. The interior chamber 36 of the
barrel has a cylindrical interior surface dimensioned
to receive the plunger piston 26 in sliding, sealing
engagement therein.
The cannula 38 is supported in the cannula collar
34 of the syringe. The cannula 38 has an axial
length with opposite proximal 42 and distal 44 ends.
The proximal end 42 is secured within the collar 34
of the syringe barrel 14 by an adhesive 46 or-in some
other suitable manner. The cannula distal end 44
outside the collar 34 tapers to a sharpened end,
e.g., a point. Typically, the cannula is constructed ,.
of a metal (e. g., stainless steel) and is from about
10 to about 18 (preferably about 16) gauge. The
cannula has a cylindrical interior.surface 48 that
surrounds an interior bore 52 of the syringe, the

CA 02196316 2005-10-04
interior bore 52 extending from the cannula distal
end 44 through the cannula 38 and the collar 34 to
the syringe barrel interior chamber 36.
The segment of the interior bare 52 that extends
through the cannula between its distal 44 and
proximal 42 ends has a constant interior diameter.
The segment of the interior bore 52 that extends from
the cannula proximal end 42 through the syringe
collar 34 to the barrel interior chamber 36 tapers as
it extends toward the interior chamber. This segment
of the interior bore 52 is surrounded by an interior
surface 54 of the syringe barrel collar 34 having a
frustoconical configuration. As in Figures 3 and 4,
the segment of the interior bore 52 surrounded by the
collar interior surface 54 begins with an interior
diameter substantially equal to that of the cannula
interior surface 48 and tapers to an interior
diameter less than that of the cannula interior
surface as it extends toward the interior chamber 36
of the syringe barrel from the cannula proximal end
42.
The sheath 16 has an axial length with a hollow
interior 62. A collar 64 surrounds an opening to the
interior at one end of the sheath and the opposite
end 66 of the sheath is closed. The collar 64 is
configured to be releasably attached around the
exterior of the syringe barrel 14 adjacent the collar
34, as in Figure 2. The sheath interior 62 is
sufficiently large to receive the syringe barrel
collar 34 and the cannula 38 therein with the collar
64 removably attached over the exterior of the
syringe barrel 14 as shown in Figure 2. A center
rod 68 is affixed to the sheath 16 within its
interior 62. The centex.ro~ 68 has an elongated
configuration with a distal end 72 secured to the
closed end 66 of the sheath and a proximal end 74
positioned outside the sheath interior 62. As seen

CA 02196316 2005-10-04
.g,
in Figure 2, the length of the rod is sufficient to
project the rod proximal end 74 completely through the
tapered segment of the interior bore 52 within the
syringe barrel collar 34 with the sheath 16 attached
to the exterior of the syringe barrel.
In a preferred embodiment of the invention, the
center rod 68 has a cylindrical configuration with a
constant diameter along its entire length. The
diameter of the center rod 68 is less than the
interior diameter of the segment of the interior bore
52 surrounded by the cannula interior surface 48, but
is larger than the interior diameter of at least a
portion of the segment of the interior bore 52
surrounded by the interior surface 54 of the syringe
barrel collar 34. With these relative diameter
dimensions of the sheath center rod 68 and the
tapered segment of the interior bore 52 extending
through the syringe barrel collar 34, at least
portions of both the segment of the interior bore 52
extending through the syringe collar 34 and the
sheath center rod 68 adjacent its proximal end 74 will
compress when the rod 68 is inserted through the
interior bore 52 and the sheath collar 64 is attached
to the exterior of the syringe barrel 14 in the
position shown in Figure 2. This compression of both
the collar interior surface 54 and the sheath center
rod 68 produces a sealing engagement between the
collar surface and center rod.
In a variant embodiment of the center rod 68, a
portion of the rod adjacent its proximal end 74 may be
tapered slightly as shown in phantom lines in Figure
3. The taper is provided to assist in insertion of
the rod proximal end 74 through the interior bore 52 at
the cannula distal end 44 when attaching the sheath
to the syringe barrel exterior. Such a taper of the
end of rod 68 is especially advantageous if the
diameter of the first segment of the bore decreases

CA 02196316 2005-10-04
-9-
abruptly, rather than tapering, to the smaller
diameter of the second bore segment.
In a further variant embodiment of the invention,
the entire center rod 68 may be constructed of a
material that is not resilient, for example a metal.
As the sheath is assembled to the syringe barrel and
the proximal end 74 of the rod is inserted through a
tapered segment of the interior bore 52, e.g., with-
in collar 34, the resilient compression of the
material of.t~e collar interior surface 54 around the
center rod proximal end 74 provides a sealing
engagement between the collar interior surface and
the center rod.
In a further variant embodiment of the invention,
the tapered segment of the collar interior surface is
replaced by a necked down portion of the interior
bore where the bore diameter changes abruptly from
the first diameter to the second diameter at an
annular wall that is perpendicular to the bore center
axis. This embodiment is illustrated in dashed lines
in Figures 4. In this embodiment the tapered rod end
74 engages against the inner peripheral edge of the
annular wall, thus producing a seal within the bore.
In all of the embodiments of the invention de-
scribed above, with the sheath 16 removably attached
to the syringe barrel 14 and the center rod 68
extending through the interior bore 52, the bore is
sealed from the barrel interior chamber 36 preventing
any substance 76 contained within the chamber from
potentially blocking the interior bore 52.

Representative Drawing
A single figure which represents the drawing illustrating the invention.
Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 2006-10-03
(86) PCT Filing Date 1995-07-14
(87) PCT Publication Date 1996-02-15
(85) National Entry 1997-01-29
Examination Requested 2002-07-03
(45) Issued 2006-10-03
Expired 2015-07-14

Abandonment History

There is no abandonment history.

Payment History

Fee Type Anniversary Year Due Date Amount Paid Paid Date
Application Fee $0.00 1997-01-29
Maintenance Fee - Application - New Act 2 1997-07-14 $100.00 1997-06-30
Registration of a document - section 124 $100.00 1997-11-12
Maintenance Fee - Application - New Act 3 1998-07-14 $100.00 1998-06-30
Maintenance Fee - Application - New Act 4 1999-07-14 $100.00 1999-07-02
Maintenance Fee - Application - New Act 5 2000-07-14 $150.00 2000-06-27
Maintenance Fee - Application - New Act 6 2001-07-16 $150.00 2001-07-05
Request for Examination $400.00 2002-07-03
Maintenance Fee - Application - New Act 7 2002-07-15 $150.00 2002-07-03
Registration of a document - section 124 $50.00 2003-05-27
Registration of a document - section 124 $50.00 2003-05-27
Maintenance Fee - Application - New Act 8 2003-07-14 $150.00 2003-06-25
Maintenance Fee - Application - New Act 9 2004-07-14 $200.00 2004-06-30
Maintenance Fee - Application - New Act 10 2005-07-14 $250.00 2005-06-27
Maintenance Fee - Application - New Act 11 2006-07-14 $250.00 2006-06-23
Final Fee $300.00 2006-07-20
Maintenance Fee - Patent - New Act 12 2007-07-16 $250.00 2007-06-18
Maintenance Fee - Patent - New Act 13 2008-07-14 $250.00 2008-06-18
Registration of a document - section 124 $100.00 2009-06-04
Maintenance Fee - Patent - New Act 14 2009-07-14 $250.00 2009-06-19
Maintenance Fee - Patent - New Act 15 2010-07-14 $450.00 2010-06-18
Maintenance Fee - Patent - New Act 16 2011-07-14 $450.00 2011-06-22
Maintenance Fee - Patent - New Act 17 2012-07-16 $450.00 2012-06-19
Maintenance Fee - Patent - New Act 18 2013-07-15 $450.00 2013-06-20
Maintenance Fee - Patent - New Act 19 2014-07-14 $450.00 2014-06-17
Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ELI LILLY AND COMPANY
Past Owners on Record
BALABAN, STEPHEN MICHAEL
MONSANTO COMPANY
MONSANTO TECHNOLOGY LLC
PHARMACIA CORPORATION
SMITH, JONATHAN PAUL
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Description 2005-10-04 10 368
Claims 2005-10-04 4 151
Cover Page 1995-07-14 1 12
Description 1995-07-14 9 295
Claims 1995-07-14 4 109
Representative Drawing 1997-06-11 1 7
Abstract 1995-07-14 1 41
Cover Page 1998-06-10 1 12
Drawings 1995-07-14 1 24
Representative Drawing 2005-11-10 1 12
Representative Drawing 2006-08-29 1 12
Cover Page 2006-08-29 1 49
Abstract 2006-10-02 1 41
Drawings 2006-10-02 1 24
Description 2006-10-02 10 368
Prosecution-Amendment 2005-10-04 11 412
Fees 1997-06-30 1 54
Assignment 1997-01-29 9 461
PCT 1997-01-29 10 448
Prosecution-Amendment 2002-07-03 1 76
Correspondence 1997-02-25 1 41
Prosecution-Amendment 2002-08-20 1 47
Assignment 2003-05-27 9 272
Fees 2003-06-25 1 43
Fees 2000-06-27 1 58
Fees 1999-07-02 1 56
Assignment 2009-06-04 4 119
Fees 2001-07-05 1 54
Fees 2002-07-03 1 62
Fees 1998-06-30 1 55
Fees 2004-06-30 1 47
Prosecution-Amendment 2005-06-01 2 36
Fees 2005-06-27 1 43
Fees 2006-06-23 1 46
Correspondence 2006-07-20 1 43
Correspondence 2009-06-05 3 63
Correspondence 2009-07-16 1 18
Correspondence 2009-07-31 1 21
Correspondence 2009-10-16 1 13
Correspondence 2009-10-16 1 16
Assignment 2009-09-01 5 213
Correspondence 2009-07-30 1 37